Alagille Syndrome and the Jagged1 Gene

 

 Buy Article Permissions and Reprints

ABSTRACT

Since the first descriptions of Alagille syndrome (syndromic bile duct paucity) 30 years ago, our appreciation of the clinical variability and complexity of this disorder has grown. In addition to the liver, Alagille syndrome is associated with abnormalities that involve the heart, eye, skeleton, kidneys, and the increasing importance of abnormalities of the central nervous system is being recognized. The developmental nature of the disorder has been proven with the identification of the disease-causing gene, Jagged1. Jagged1 is a cell surface protein that functions in an embryologically important signaling pathway, known as the Notch signaling pathway. Identification of the role of Jagged1 (JAG1) in the etiology of Alagille syndrome has improved diagnosis for this variably expressed disorder. In this review, we summarize information on the range of clinical abnormalities of the liver and other affected organs in affected individuals. Genetic studies have demonstrated the range of defects in JAG1 that cause Alagille syndrome. Mutations in JAG1 can be identified in 70% of Alagille syndrome patients, and they are inherited in 30-50%. These mutations include total gene deletions as well as mutations (frameshift, missense, and nonsense) in almost all regions of the 26 exons of the Jagged1 gene. This review focuses on clinical and genetic features of Alagille syndrome.

REFERENCES

• 1 Alagille D, Habib E C, Thomassin N. L'atresie des voies biliaires extrahepatiques permeables chez l'enfant.  J Par Pediatr . 1969;  301-318
  PubMedGoogle Scholar
• 2 Alagille D, Odievre M, Gautier M. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur.  J Pediatr . 1975;  86 63-71
  CrossrefPubMedGoogle Scholar
• 3 Watson G H, Miller V. Arteriohepatic dysplasia: familial pulmonary arterial stenosis with neonatal liver disease.  Arch Dis Child . 1973;  48 459-466
  PubMedGoogle Scholar
• 4 Li L, Krantz I D, Deng Y. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.  Nat Genet . 1997;  16 243-251
  CrossrefPubMedGoogle Scholar
• 5 Oda T, Elkahloun A G, Pike B L. Mutations in the human Jagged1 gene are responsible for Alagille syndrome.  Nat Genet . 1997;  16 235-242
  CrossrefPubMedGoogle Scholar
• 6 Alagille D, Estrada A, Hadchouel M. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases.  J Pediatr . 1987;  110 195-200
  PubMedGoogle Scholar
• 7 Deprettere A, Portmann B, Mowat A P. Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood.  J Pediatr Gastroenterol Nutr . 1987;  6 865-871
  PubMedGoogle Scholar
• 8 Hoffenberg E J, Narkewicz M R, Sondheimer J M. Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy.  J Pediatr . 1995;  127 220-224
  PubMedGoogle Scholar
• 9 Emerick K M, Rand E B, Goldmuntz E. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.  Hepatology . 1999;  29 822-829
  CrossrefPubMedGoogle Scholar
• 10 Quiros-Tejeira R E, Ament M E, Heyman M B. Variable morbidity in Alagille syndrome: a review of 43 cases.  J Pediatr Gastroenterol Nutr . 1999;  29 431-437
  CrossrefPubMedGoogle Scholar
• 11 Crosnier C, Lykavieris P, Meunier-Rotival M. Alagille syndrome: the widening spectrum of arteriohepatic dysplasia.  Clin Liver Dis . 2000;  4 765-778
  PubMedGoogle Scholar
• 12 Kahn E. Paucity of interlobular bile ducts: arteriohepatic dysplasia and nonsyndromic duct paucity.  Perspect Pediatr Pathol . 1991;  14 168-215
  PubMedGoogle Scholar
• 13 Hashida Y, Yunis E J. Syndromatic paucity of interlobular bile ducts: hepatic histopathology of the early and endstage liver.  Pediatr Pathol . 1988;  8 1-15
  PubMedGoogle Scholar
• 14 Cardona J, Houssin D, Gauthier F. Liver transplantation in children with Alagille syndrome-a study of twelve cases.  Transplantation . 1995;  60 339-342
  PubMedGoogle Scholar
• 15 Gurkan A, Emre S, Fishbein T M. Unsuspected bile duct paucity in donors for living-related liver transplantation: two case reports.  Transplantation . 1999;  67 416-418
  PubMedGoogle Scholar
• 16 Silberbach M, Lashley D, Reller M D. Arteriohepatic dysplasia and cardiovascular malformations.  Am Heart J . 1994;  127 695-699
  CrossrefPubMedGoogle Scholar
• 17 Krantz I D, Smith R, Colliton R P. Jagged1 mutations in patients ascertained with isolated congenital heart defects.  Am J Med Genet . 1999;  84 56-60
  CrossrefPubMedGoogle Scholar
• 18 Loomes K M, Underkoffler L A, Morabito J. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome.  Hum Mol Genet . 1999;  8 2443-2449
  CrossrefPubMedGoogle Scholar
• 19 Rachmel A, Zeharia A, Neuman-Levin M. Alagille syndrome associated with moyamoya disease.  Am J Med Genet . 1989;  33 89-91
  CrossrefPubMedGoogle Scholar
• 20 Woolfenden A R, Albers G W, Steinberg G K. Moyamoya syndrome in children with Alagille syndrome: additional evidence of a vasculopathy.  Pediatrics . 1999;  103 505-508
  CrossrefPubMedGoogle Scholar
• 21 Joutel A, Corpechot C, Ducros A. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.  Nature . 1996;  383 707-710
  CrossrefPubMedGoogle Scholar
• 22 Martin S R, Garel L, Alvarez F. Alagille's syndrome associated with cystic renal disease.  Arch Dis Child . 1996;  74 232-235
  PubMedGoogle Scholar
• 23 Russo P A, Ellis D, Hashida Y. Renal histopathology in Alagille's syndrome.  Pediatr Pathol . 1987;  7 557-568
  PubMedGoogle Scholar
• 24 Berard E, Sarles J, Triolo V. Renovascular hypertension and vascular anomalies in Alagille syndrome.  Pediatr Nephrol . 1998;  12 121-124
  CrossrefPubMedGoogle Scholar
• 25 Tolia V, Dubois R S, Watts Jr B F. Renal abnormalities in paucity of interlobular bile ducts.  J Pediatr Gastroenterol Nutr . 1987;  6 971-976
  PubMedGoogle Scholar
• 26 Habib R, Dommergues J P, Gubler M C. Glomerular mesangiolipidosis in Alagille syndrome (arteriohepatic dysplasia).  Pediatr Nephrol . 1987;  1 455-464
  CrossrefPubMedGoogle Scholar
• 27 Hyams J S, Berman M M, Davis B H. Tubulointerstitial nephropathy associated with arteriohepatic dysplasia.  Gastroenterology . 1983;  85 430-434
  PubMedGoogle Scholar
• 28 Schonck M, Hoorntje S, van Hooff J. Renal transplantation in Alagille syndrome.  Nephrol Dialysis Transplantation . 1998;  13 197-199
  PubMedGoogle Scholar
• 29 Hingorani M, Nischal K K, Davies A. Ocular abnormalities in Alagille syndrome.  Ophthalmology . 1999;  106 330-337
  CrossrefPubMedGoogle Scholar
• 29a McDonald-McGinn D M, Kirschner R, Goldmuntz E. The Philadelphia story: the 22q11.2 deletion: Report on 250 patients.  Genet Counseling . 1999;  10 11-24
  PubMedGoogle Scholar
• 30 Nischal K K, Hingorani M, Bentley C R. Ocular ultrasound in Alagille syndrome: a new sign.  Ophthalmology . 1997;  104 79-85
  CrossrefPubMedGoogle Scholar
• 31 Wells K K, Pulido J S, Judisch G F. Ophthalmic features of Alagille syndrome (arteriohepatic dysplasia).  J Pediatr Ophthalmol Strabismus . 1993;  30 130-135
  PubMedGoogle Scholar
• 32 Heubi J E, Higgins J V, Argao E A. The role of magnesium in the pathogenesis of bone disease in childhood cholestatic liver disease: a preliminary report.  J Pediatr Gastroenterol Nutr . 1997;  25 301-306
  CrossrefPubMedGoogle Scholar
• 33 Bulman M P, Kusumi K, Frayling T M. Mutations in the human Delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis.  Nat Genet . 2000;  24 438-441
  PubMedGoogle Scholar
• 34 Chong S KF, Lindridge J, Moniz C. Exocrine pancreatic insufficiency in syndromic paucity of interlobular bile ducts.  J Pediatr Gastroenterol Nutr . 1989;  9 445-449
  PubMedGoogle Scholar
• 34a LaBrecque D R, Mitros F A, Nathan R J. Four generations of arteriohepatic dysplasia.  Hepatology . 1982;  2 467-474
  PubMedGoogle Scholar
• 35 Shulman S A, Hyams J S, Gunta R. Arteriohepatic dysplasia (Alagille syndrome): extreme variability among affected family members.  Am J Med Genet . 1984;  19 325-332
  CrossrefPubMedGoogle Scholar
• 36 Dhorne-Pollet S, Deleuze J F, Hadchouel M. Segregation analysis of Alagille syndrome.  J Med Genet . 1994;  31 453-457
  PubMedGoogle Scholar
• 37 Spinner N B, Rand E B, Fortina P. Cytologically balanced t(2;20) in a two-generation family with Alagille syndrome: cytogenetic and molecular studies.  Am J Hum Genet . 1994;  55 238-243
  PubMedGoogle Scholar
• 38 Krantz I D, Rand E B, Genin A. Deletions of 20p12 in Alagille syndrome: frequency and molecular characterization.  Am J Med Genet . 1997;  70 80-86
  CrossrefPubMedGoogle Scholar
• 39 Artavanis-Tsakonas S, Rand M D, Lake R J. Notch signaling: cell fate control and signal integration in development.  Science . 1999;  284 770-776
  CrossrefPubMedGoogle Scholar
• 40 Ellison L W, Bird J, West D C. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.  Cell . 1991;  66 649-661
  CrossrefPubMedGoogle Scholar
• 41 Jones E A, Clement-Jones M, Wilson D I. JAGGED1 expression in human embryos: correlation with the Alagille syndrome phenotype.  J Med Genet . 2000;  37 663-668
  CrossrefPubMedGoogle Scholar
• 42 Crosnier C, Attie-Bitach T, Encha-Razavi F. JAGGED1 gene expression during human embryogenesis elucidates the wide phenotypic spectrum of Alagille syndrome.  Hepatology . 2000;  32 574-581
  CrossrefPubMedGoogle Scholar
• 43 Shimizu K, Chiba S, Kumano K. Mouse jagged1 physically interacts with notch2 and other notch receptors. Assessment by quantitative methods.  J Biol Chem . 1999;  274 32961-32969
  CrossrefPubMedGoogle Scholar
• 44 Lindsell C E, Shawber D J, Boulter J. Jagged: a mammalian ligand that activates Notch1.  Cell . 1995;  80 909-917
  CrossrefPubMedGoogle Scholar
• 45 Spinner N B, Colliton R P, Crosnier C. Jagged1 mutations in Alagille syndrome.  Hum Mutat . 2001;  17 18-33
  CrossrefPubMedGoogle Scholar
• 46 Krantz I D, Colliton R P, Genin A. Spectrum and frequency of Jagged1 (JAG1) mutations in Alagille syndrome patients and their families.  Am J Hum Genet . 1998;  62 1361-1369
  CrossrefPubMedGoogle Scholar
• 47 Crosnier C, Driancourt C, Raynaud N. Mutations in JAGGED1 gene are predominantly sporadic in Alagille syndrome.  Gastroenterology . 1999;  116 1141-1148
  PubMedGoogle Scholar
• 48 Morrissette J JD, Colliton R P, Spinner N B. Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome.  Hum Molec Genet . 2001;  10 405-413
  PubMedGoogle Scholar
• 49 Sun X, Artavanis-Tsakonas S. The intracellular deletions of Delta and Serrate define dominant negative forms of the Drosophila Notch ligands.  Development . 1996;  122 2465-2474
  PubMedGoogle Scholar
• 50 Eldadah Z A, Hamosh A, Biery N J. Familial tetralogy of Fallot caused by mutation in the jagged1 gene.  Hum Mol Genet . 2001;  10 163-169
  CrossrefPubMedGoogle Scholar